Core Insights - Wall Street analysts expect Ventas (VTR) to report quarterly earnings of $0.85 per share, reflecting a year-over-year increase of 6.3% [1] - Revenues are projected to be $1.37 billion, which represents a 14.3% increase from the same quarter last year [1] - The consensus EPS estimate has been revised upward by 0.7% over the past 30 days, indicating a collective reassessment by analysts [1] Revenue Estimates - Analysts estimate 'Revenues- Rental income- Outpatient medical & research portfolio' to be $222.56 million, showing a 1.7% increase from the prior year [4] - 'Revenues- Interest and other income' is expected to be $2.98 million, indicating a significant decrease of 38.2% from the previous year [4] - 'Revenues- Resident fees and services' are projected to reach $977.05 million, reflecting a 19.5% increase year-over-year [5] - 'Revenues- Rental income- Triple-net leased' is estimated at $153.51 million, showing a slight decrease of 0.3% from the year-ago quarter [5] - 'Revenues- Third party capital management revenues' are expected to be $4.38 million, indicating a 1.1% increase from the prior year [6] Other Financial Metrics - Depreciation and amortization is projected to reach $319.33 million [6] - Ventas shares have increased by 3.3% over the past month, compared to a 3.6% increase in the Zacks S&P 500 composite [6] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]
Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics